| Element | Current quarter | Similar quarter for previous year | % Change current | Previous quarter | % Change previous |
|---|---|---|---|---|---|
| Net profit (loss) |
-
|
-
|
-
|
-
|
0
|
| Gross profit (loss) |
-
|
0.28
|
-
|
0.19
|
-
|
| Operational profit (loss) |
-
|
-
|
-
|
-
|
-
|
| All figures are in (Millions) Saudi Arabia, Riyals | |||||
| Element | Current period | Similar period for previous year | % Change |
|---|---|---|---|
| Net profit (loss) |
-
|
1.8
|
- |
| Gross profit (loss) |
0.32
|
7.3
|
- |
| Operational profit (loss) |
-
|
2.5
|
- |
| Earning or loss per share, Riyals |
-
|
0.16
|
- |
| All figures are in (Millions) Saudi Arabia, Riyals | |||
| Element | EXPLAINATION |
|---|---|
| Reasons of increase (decrease) for quarter compared with same quarter last year | Loss reason from declining sales and profits coming from delayed sale of products from Asian countries in the domestic market, also the increase of general and administrative expenses from the added administrative expenses for Sara Medical factory Devices and cancel the running contract of plant with union Zahad company and charged with general and administrative expenses 1.2 million SR. ,In addition to company's restructuring and development export strategy in demand markets, also re-administrative restructuring of Sara Medical factory devices and plan studies to develop products to align domestic and external market |
| Reasons of increase (decrease) for period compared with same period last year | Loss reason from declining sales and profits coming from delayed sale of products from Asian countries in the domestic market, also the increase of general and administrative expenses from the added administrative expenses for Sara Medical factory Devices and cancel the running contract of plant with union Zahad company and charged with general and administrative expenses 1.2 million SR. despite of income rising , In addition to company's restructuring and development export strategy in demand markets, also re-administrative restructuring of Sara Medical factory devices and plan studies to develop products to align domestic and external market |
| Reasons of increase (decrease) for quarter compared with previous quarter | The reason for high losses in the fourth quarter than the previous quarter coming from the decrease the other income and cancellation contract of Sarah Medical factory devices. |
| Other notes | The total sales during the current quarter to (-1,228,035) thousand riyals compared to 116,841,194 riyals in the same period of the previous year, The total sales during the current period to 623,392 riyals compared to 589,014,537 riyals during the same period last year, a decrease of 99,89%. The total shareholders' equity to shareholders as of December 31, 2016 up to 113,395,776 riyals, compared to SAR 123,592,475, as of 31 December 2015, a decrease of 8,25%. |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.